Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $37,581 | $30,645 | $24,036 | $1,420 |
| - Cash | $5,055 | $6,151 | $7,419 | $8,000 |
| + Debt | $3,017 | $3,349 | $1,531 | $1,943 |
| Enterprise Value | $35,543 | $27,843 | $18,148 | -$4,637 |
| Revenue | $29,267 | $23,325 | $17,025 | $13,378 |
| % Growth | 25.5% | 37% | 27.3% | – |
| Gross Profit | $18,888 | $20,193 | $842 | -$765 |
| % Margin | 64.5% | 86.6% | 4.9% | -5.7% |
| EBITDA | -$6,723 | -$5,979 | -$9,482 | -$7,888 |
| % Margin | -23% | -25.6% | -55.7% | -59% |
| Net Income | -$9,059 | -$8,790 | -$15,293 | -$7,496 |
| % Margin | -31% | -37.7% | -89.8% | -56% |
| EPS Diluted | -0.037 | -0.043 | -0.096 | -0.051 |
| % Growth | 15.1% | 54.9% | -89.1% | – |
| Operating Cash Flow | -$6,150 | -$7,857 | -$6,721 | -$4,683 |
| Capital Expenditures | -$298 | -$449 | -$800 | -$5,591 |
| Free Cash Flow | -$6,448 | -$8,306 | -$7,521 | -$10,274 |